• Latest Posts

JW Therapeutics receives approval for relapsed or refractory follicular lymphoma drug

Trial starts for treatment of warm autoimmune hemolytic anemia

CanSinoBIO to present latest data on inhaled COVID vaccine

NeuShen Therapeutics closes $20M pre-A financing

Positive results from study of drug to treat patients with breast cancer published

Bioheng Biotech has positive CAR-T cell therapy results published in academic journal


Angel Pharma announces approval of IND application for clinical trial of mupadolimab

Everest Medicines gets go-ahead for renal disease drug study

Himalaya Therapeutics publishes data on cancer treatment

Investment of €130M made by Merck’s MilliporeSigma for life-saving therapies

First patient dosed in China trial with drug to treat non-Hodgkin lymphoma

In Depth 7 Sep 2022

The biggest private biotech investments in August 2022